⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CYTK News
Cytokinetics Inc.
Cytokinetics Announces Call for Proposals for Annual Corporate Giving Program
globenewswire.com
CYTK
Cytokinetics bringt MYQORZO® (aficamten) in der Europäischen Union auf den Markt; der erste kommerzielle Vertrieb erfolgt in Deutschland
globenewswire.com
CYTK
Cytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in Germany
globenewswire.com
CYTK
Form 8-K
sec.gov
CYTK
Cytokinetics to Participate in June Investor Conferences
globenewswire.com
CYTK
Cytokinetics to Hold Annual Meeting of Stockholders
globenewswire.com
CYTK
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
globenewswire.com
CYTK
Cytokinetics to Host Annual Symposium on Contemporary Landscapes in Muscle Biology (CLIMB)
globenewswire.com
CYTK
Cytokinetics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
globenewswire.com
CYTK
Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026
globenewswire.com
CYTK